NO20051024L - Fremgangsmate for diagnostisering av multippel sklerose - Google Patents

Fremgangsmate for diagnostisering av multippel sklerose

Info

Publication number
NO20051024L
NO20051024L NO20051024A NO20051024A NO20051024L NO 20051024 L NO20051024 L NO 20051024L NO 20051024 A NO20051024 A NO 20051024A NO 20051024 A NO20051024 A NO 20051024A NO 20051024 L NO20051024 L NO 20051024L
Authority
NO
Norway
Prior art keywords
multiple sclerosis
procedure
diagnosing multiple
diagnosing
glycans
Prior art date
Application number
NO20051024A
Other languages
English (en)
Norwegian (no)
Inventor
Avinoam Dukler
Mikael Schwarz
Ari Gargir
Nir Dotan
Original Assignee
Glycominds Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glycominds Ltd filed Critical Glycominds Ltd
Publication of NO20051024L publication Critical patent/NO20051024L/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/285—Demyelinating diseases; Multipel sclerosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Testing Of Engines (AREA)
  • Heat Treatment Of Steel (AREA)
  • Sorption Type Refrigeration Machines (AREA)
  • Steering Control In Accordance With Driving Conditions (AREA)
NO20051024A 2002-08-02 2005-02-25 Fremgangsmate for diagnostisering av multippel sklerose NO20051024L (no)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US40091402P 2002-08-02 2002-08-02
US44707603P 2003-02-13 2003-02-13
US46298403P 2003-04-15 2003-04-15
US47323103P 2003-05-23 2003-05-23
PCT/IB2003/003878 WO2004015420A1 (en) 2002-08-02 2003-08-04 Method for diagnosing multiple sclerosis

Publications (1)

Publication Number Publication Date
NO20051024L true NO20051024L (no) 2005-05-02

Family

ID=31721743

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20051024A NO20051024L (no) 2002-08-02 2005-02-25 Fremgangsmate for diagnostisering av multippel sklerose

Country Status (18)

Country Link
US (2) US7537900B2 (pt)
EP (1) EP1529216B1 (pt)
JP (2) JP4721703B2 (pt)
AT (1) ATE376672T1 (pt)
AU (1) AU2003263409B2 (pt)
BR (1) BR0313194A (pt)
CA (1) CA2494422A1 (pt)
CY (1) CY1107859T1 (pt)
DE (1) DE60317070T2 (pt)
DK (1) DK1529216T3 (pt)
ES (1) ES2297248T3 (pt)
IL (1) IL166539A (pt)
MX (1) MXPA05001270A (pt)
NO (1) NO20051024L (pt)
NZ (1) NZ585114A (pt)
PL (1) PL210512B1 (pt)
PT (1) PT1529216E (pt)
WO (1) WO2004015420A1 (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003263409B2 (en) * 2002-08-02 2010-05-27 Glycominds Ltd. Method for diagnosing multiple sclerosis
US7592150B2 (en) 2003-12-03 2009-09-22 Glycominds, Ltd Method for diagnosing diseases based on levels of anti-glycan antibodies
EP1692519B1 (en) 2003-12-03 2010-06-02 Glycominds Ltd. Method for diagnosing diseases based on levels of anti-glycan antibodies
JP2008504531A (ja) * 2004-06-24 2008-02-14 ザ スクリップス リサーチ インスティテュート 切断可能なリンカーを有するアレイ
US8216791B2 (en) * 2005-01-31 2012-07-10 Glycominds Ltd. Method for diagnosing multiple sclerosis
US7572592B2 (en) * 2005-01-31 2009-08-11 Glycominds Ltd Method for diagnosing multiple sclerosis
EP2517727A3 (en) * 2005-09-29 2013-10-30 Caprion Proteomics USA, LLC Biomarkers for multiple sclerosis and methods of use thereof
US20100203569A1 (en) * 2009-02-12 2010-08-12 Glycominks LTD Method for Evaluating Risk in Multiple Sclerosis
US20120190581A1 (en) * 2009-08-25 2012-07-26 The Johns Hopkins University Detection of Auto-Antibodies to Specific Glycans as Diagnostic Tests for Autoimmune Diseases
KR20160132034A (ko) 2014-03-13 2016-11-16 우니페르시테트 바젤 미엘린-관련 당단백질에 대한 IgM 항체와 결합하는 탄수화물 리간드
WO2016026143A1 (en) * 2014-08-22 2016-02-25 Huiru Wang Saccharide-based biomarkers and therapeutics
WO2016123565A1 (en) 2015-01-30 2016-08-04 The Regents Of The University Of California N-acetyl glucosamine as a biomarker of ms disease course
US11091591B2 (en) 2015-09-16 2021-08-17 Universität Basel Carbohydrate ligands that bind to antibodies against glycoepitopes of glycosphingolipids
AU2017286979B2 (en) 2016-07-01 2023-04-27 Dignity Health Diagnostic or predictor of relapsing remitting multiple sclerosis
WO2019195448A1 (en) * 2018-04-03 2019-10-10 Creatics Llc Methods for cancer detection by evaluation of glycan-binding patterns of immunoglobulins in gastrointestinal lavage fluid samples

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4281061A (en) * 1979-07-27 1981-07-28 Syva Company Double antibody for enhanced sensitivity in immunoassay
US5030560A (en) * 1988-11-04 1991-07-09 Immucor, Inc. Method for drying mammalian cells for use in solid phase immunoassays and articles incorporating same
JPH02161357A (ja) * 1988-12-15 1990-06-21 Tosoh Corp 免疫測定用材料の安定化方法
NZ513533A (en) * 1999-02-17 2003-11-28 Glycominds Ltd Combinatorial complex carbohydrate libraries and methods for the manufacture and uses thereof
US20010051349A1 (en) 2000-02-17 2001-12-13 Glycominds Ltd. Combinatorial complex carbohydrate libraries and methods for the manufacture and uses thereof
US6762032B1 (en) * 1999-08-23 2004-07-13 Biocrystal, Ltd. Compositions, assay kits, and methods for use related to a disease condition comprising multiple sclerosis and/or a pro-MS immune response
CN1406153A (zh) * 2000-01-10 2003-03-26 基因谱公司 线性探针载体
AU2001288431A1 (en) 2000-08-28 2002-03-13 The Trustees Of Columbia University In The City Of New York Detection of anti-glycolipid antibodies by latex agglutination assay
ITFI20010114A1 (it) 2001-06-22 2002-12-22 Univ Firenze Glicopeptidi,loro preparazione e loro uso nella diagnosi o nel trattamento terapeutico della sclerosi multipla
US20040241763A1 (en) * 2002-08-02 2004-12-02 Nir Dotan Method for diagnosing multiple sclerosis
AU2003263409B2 (en) * 2002-08-02 2010-05-27 Glycominds Ltd. Method for diagnosing multiple sclerosis
US7572592B2 (en) * 2005-01-31 2009-08-11 Glycominds Ltd Method for diagnosing multiple sclerosis

Also Published As

Publication number Publication date
US20040077023A1 (en) 2004-04-22
CA2494422A1 (en) 2004-02-19
WO2004015420A8 (en) 2004-09-10
NZ585114A (en) 2011-09-30
ATE376672T1 (de) 2007-11-15
US7537900B2 (en) 2009-05-26
IL166539A0 (en) 2006-01-15
WO2004015420B1 (en) 2004-04-29
AU2003263409B2 (en) 2010-05-27
EP1529216A1 (en) 2005-05-11
JP4721703B2 (ja) 2011-07-13
ES2297248T3 (es) 2008-05-01
JP2006501441A (ja) 2006-01-12
EP1529216B1 (en) 2007-10-24
JP2009258138A (ja) 2009-11-05
US20100081160A1 (en) 2010-04-01
IL166539A (en) 2010-11-30
CY1107859T1 (el) 2013-06-19
AU2003263409A1 (en) 2004-02-25
MXPA05001270A (es) 2005-08-03
DE60317070D1 (de) 2007-12-06
DE60317070T2 (de) 2008-07-24
BR0313194A (pt) 2005-07-12
WO2004015420A1 (en) 2004-02-19
PT1529216E (pt) 2008-01-30
PL374869A1 (en) 2005-11-14
PL210512B1 (pl) 2012-01-31
DK1529216T3 (da) 2008-02-25

Similar Documents

Publication Publication Date Title
NO20051024L (no) Fremgangsmate for diagnostisering av multippel sklerose
RS51523B (sr) Rana dijagnoza konformacionih bolesti
GB2457856A (en) Cement bond analysis
DE60228557D1 (de) Candida-nachweis
WO2004113896A3 (en) System and method for analysis of a biological fluid by the use electrical means
WO2004113912A8 (en) System and method for determining a temperature during analysis of biological fluid
EA200601463A1 (ru) Способы и устройства для неинвазивного получения количественной информации о веществах в живых организмах
DE60331345D1 (de) Probensubstrat zur biologischen untersuchung
AU2002348289A8 (en) Method of using a non-antibody protein to detect and measure an analyte
DE602005024254D1 (pt)
AU2002233800A1 (en) Method and kit for predicting cancer
MXPA02009476A (es) Sistema y metodo para analisis de sensibilidad de transision de modelo.
DE50212790D1 (de) Verfahren zum nachweis von blutzell-antigenen und gegen diese gerichtete antikörper
ATE526582T1 (de) Generisches verfahren für latex- agglutinationstests
DK1495056T3 (da) Fremgangsmåde til analyse af antistofdisulfidisomere
DE60231845D1 (de) Diagnoseverfahren für proteinprofilierung
EP1445327A4 (en) SCREENING METHOD FOR A MEDICAMENT ACTIVE ON THE CELL WALL
GB0317304D0 (en) An analysis apparatus arranged to analyse data and detect change and related methods
DK1171157T3 (da) Anvendelse af glucose-6-phosphat-isomerase og antistoffer derimod til diagnosticering og behandling af arthritis, og test for anti-arthritis-forbindelser
JP2005278628A5 (pt)
EP1801231A4 (en) METHOD OF SCREENING THE BAFF SUPPRESSOR OR INHIBITOR
DE69121877D1 (de) Verfahren zur Messung der Aktivität angiotensinkonvertierenden Enzyms in biologischen Proben
RU94029889A (ru) Способ прогнозирования течения кариеса у детей
UA70267A (en) Method for diagnosing the stage of the diabetic angiopathy process
FR2846009B1 (fr) Criblage de molecules a activite anti-prion:kits, methodes et molecules criblees

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application